美国FDA已批准Wyeth－Ayerst公司的抗抑郁药venlafaxine（商品名Effexor），认为该药是新类型抗抑郁药——5－HT一去甲肾卜腺素（NE）重摄取抑制剂（SNRI）中的第一个品种。1993年9月该药首次在新西兰获得批准，但至1993年底尚未上市，公司说1994年早春该药即可上市。在全世界8 The FDA has approved Wyeth-Ayerst’s antidepressant venlafaxine (brand name Effexor) as a new type of antidepressant - a 5-HT-SNN reuptake inhibitor (SNRI) In the first species. The drug was approved for the first time in New Zealand in September 1993, but was not yet available by the end of 1993 and the company said the drug will be available in early spring 1994. All over the world